Interwest Venture Management CO Cidara Therapeutics, Inc. Transaction History

Interwest Venture Management CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 19, 2021	SELL	$1.48 - $2.35 $2.01 Million - $3.19 Million	-1,356,813 Closed	0 $0
Q3 2017 Oct 11, 2017	BUY	$5.75 - $8.1 $7.8 Million - $11 Million	1,356,813	1,356,813 $11 Million

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Interwest Venture Management CO, based on Form 13F filings with the SEC.

Stay updated on Interwest Venture Management CO with notifications on news.